Kolexia
Froudarakis Marios
Pneumologie
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
102 Activités
359 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Épanchement pleural Fibrose Épanchement pleural malin Carcinomes Carcinome épidermoïde Syndrome d'apnées obstructives du sommeil Métastase tumorale Mésothéliome

Industries

Menarini
10 collaboration(s)
Dernière en 2023
VitalAire
5 collaboration(s)
Dernière en 2023
Chiesi
3 collaboration(s)
Dernière en 2023
Sanofi
1 collaboration(s)
Dernière en 2021

Dernières activités

Comment from the authors: the tests combination in patients with lung cancer and malignant pleural effusion.
Journal of thoracic disease   12 octobre 2023
Clinical Outcomes Beyond 1L -TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Anticancer research   27 avril 2023
The role of an interventional pulmonologist in the management of metastatic pleural effusions (MPE).
Revue des maladies respiratoires   11 octobre 2022
Chest ultrasound findings in usual interstitial pneumonia patterns: a pilot study.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace   07 septembre 2022
Prognostic role of immune microenvironment in pleural metastases from breast and lung adenocarcinomas.
Annals of translational medicine   19 mai 2022
Clinical long-term outcome of non-specific pleuritis (NSP) after surgical or medical thoracoscopy.
Journal of thoracic disease   15 avril 2022
Two years progression-free survival under vinorelbine metronomic therapy of a patient with metastatic epithelioid hemangioendothelioma.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace   01 avril 2022
Comparison of cytology, chest computed and positron emission tomography findings in malignant pleural effusion from lung cancer.
Journal of thoracic disease   31 mars 2022
Lung function changes after chemoradiation therapy in patients with lung cancer treated by three usual platinum combinations.
Journal of thoracic disease   30 mars 2022
Feasibility and safety of treatment switch from Pirfenidone to Nintedanib in patients with idiopathic pulmonary fibrosis: a real-world observational study.
European review for medical and pharmacological sciences   23 mars 2022